Patricia Farris
Metairie, LANPI 1598765893
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (59.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 67.5% of it on its own, with 25 other manufacturers making up the rest.
Across 119 payments — averaging $1159.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$93K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$22K
- Dermira, Inc.$21K
- Arcutis Biotherapeutics, Inc.$433
- Novartis$243
- Galderma Laboratories, L.p.$158
- plus $1K from 20 others
What the payments were for
- Consulting fees$20,89015%
- Speaking & faculty fees$29,00021%
- Grants$82,50060%
- Travel & lodging$2,0211%
- Food & beverage$3,6173%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $93,219 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 17 | $22,349 |
| Dermira, Inc. | 17 | $20,558 |
| Arcutis Biotherapeutics, Inc. | 5 | $433 |
| Novartis | 8 | $243 |
| Galderma Laboratories, L.p. | 5 | $158 |
| Revance Therapeutics, Inc. | 2 | $143 |
| Pfizer | 8 | $127 |
| Dermavant Sciences, Inc. | 1 | $125 |
| Sanofi | 4 | $88 |
| Incyte Corporation | 1 | $76 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $68 |
| Almirall LLC | 4 | $65 |
| Merz North America, Inc. | 2 | $51 |
| Aclaris Therapeutics, Inc. | 2 | $48 |
| Lilly USA, LLC | 3 | $47 |
| UCB, Inc. | 2 | $42 |
| Mayne Pharma Commercial LLC | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Genentech USA, Inc. | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Amgen | 1 | $21 |
| LEO Pharma Inc. | 1 | $15 |
| Bristol Myers Squibb | 1 | $15 |
| Journey Medical Corporation | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.